Comment letters, testimony, policy briefs, and reports from California Life Sciences on the issues shaping the state’s life sciences sector.
ResourceOfficial Complaint to Block CMS GLOBE RuleView resource →ResourceGLOBE Fact SheetView resource →One-PagerMost Favored Nation (MFN) Fact SheetView resource →Policy BriefFixing Prior AuthorizationReforms to Address the Overuse and Abuse of Prior AuthorizationView resource →Policy BriefEnsuring Stable Tariff PolicyTariff Volatility is Stalling US InnovationView resource →Policy BriefPreserving the Orphan Cures ActMaintaining Progress Made for Californians with Rare DiseaseView resource →Policy BriefReforming Abusive PBM PracticesWay to Ensure Californians Have Affordable Access to MedicineView resource →Policy BriefRestoring the ORPHAN Drug Tax CreditMaintaining Progress for Californians with Rare DiseaseView resource →Policy BriefSupporting NIH Research FundingDefending and Sustaining the Nation's Critical NIH Research EnterpriseView resource →Policy BriefMost Favored Nation (MFN) Policy Impact BriefView resource →Policy BriefExpanding Medical Device E-LabelingSafer and More Effective Use of Devices Through Non-Physical LabelingView resource →Policy BriefMFN ModelsGLOBE and GUARD Regulatory AnalysisView resource →Policy BriefFixing the ‘Pill Penalty’Preserving Innovation for California PatientsView resource →Policy BriefClosing the Coverage Gap for Emerging TechnologiesEnsuring Californians Can Access Breakthrough TechnologiesView resource →Comment Letter · Feb 23, 2026CLS Comment Letter on GLOBE and GUARDView resource →
No resources match those filters.
For Policymakers & Staff
Let’s Talk Life Sciences
Looking for data, an expert, or a site visit in your district? Our policy team will connect you with the people and research behind California’s life sciences sector.
Sam Chung · Senior Vice President, Government Relations & External Affairs